ST-segment elevation resolution and outcome in patients treated with primary angioplasty and glucose-insulin-potassium infusion

American Heart Journal

Volumn 149, Issue 6, 2005, Pages 1135.e1-1135.e9

  Van Der Horst, Iwan C C ^a   De Luca, Giuseppe ^b   Ottervanger, Jan Paul ^b   De Boer, Menko Jan ^b   Hoorntje, Jan C A ^b   Suryapranata, Harry ^b   Dambrink, Jan Henk E ^b   Gosselink, A T Marcel ^b   Zijlstra, Felix ^a   Van 't Hof, Arnoud W J ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ISALA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; POTASSIUM;

ADULT; AGED; ANGIOPLASTY; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; GLUCOSE INFUSION; HEART INFARCTION; HUMAN; INFUSION; INSULIN INFUSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; ST SEGMENT ELEVATION; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 20544447270     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.03.023     Document Type: Article

References (56)

1. J.A. De Lemos, and E. Braunwald ST segment resolution as a tool for assessing the efficacy of reperfusion therapy J Am Coll Cardiol 38 2001 1283 1294
2. C.J. Pepine Prognostic markers in thrombolytic therapy: looking beyond mortality Am J Cardiol 78 1996 24 27
3. H.A. Cooper, J.A. De Lemos, and D.A. Morrow Minimal ST-segment deviation: a simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administration Am Heart J 144 2002 790 795
4. R.K. Saran, M. Been, and S.S. Furniss Reduction in ST segment elevation after thrombolysis predicts either coronary reperfusion or preservation of left ventricular function Br Heart J 64 1990 113 117
5. R. Schroder, R. Dissmann, and T. Bruggemann Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction J Am Coll Cardiol 24 1994 384 391
6. A.W. van 't Hof, A. Liem, and M.J. de Boer Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial Infarction Study Group Lancet 350 1997 615 619
7. A.W. van 't Hof, A. Liem, and H. Suryapranata Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group Circulation 97 1998 2302 2306
8. M.J. Claeys, J. Bosmans, and L. Veenstra Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome Circulation 99 1999 1972 1977
9. R. Corbalan, G. Larrain, and C. Nazzal Association of noninvasive markers of coronary artery reperfusion to assess microvascular obstruction in patients with acute myocardial infarction treated with primary angioplasty Am J Cardiol 88 2001 342 346
10. A.J. Dalby, O.L. Bricknell, and L.H. Opie Effect of glucose-insulin- potassium infusions on epicardial ECG changes and on myocardial metabolic changes after coronary artery ligation in dogs Cardiovasc Res 15 1981 588 598
11. T. Haneda, W. Ganz, and M.H. Burnam Metabolic effects of glucose-insulin-potassium in the ischemic myocardium Jpn Heart J 19 1978 376 382
12. L.H. Opie, and P. Owen Effect of glucose-insulin-potassium infusions on arteriovenous differences of glucose of free fatty acids and on tissue metabolic changes in dogs with developing myocardial infarction Am J Cardiol 38 1976 310 321
13. T. Ueno, T. Ishiyama, and Y. Morita An experimental study of the effect of glucose-insulin-potassium solution on energy metabolism of infarcted cardiac muscle Recent Advan Stud Cardiac Struct Metab 11 1976 549 554
14. D. Sodi-Pallares, M.R. Testelli, and B.L. Fishleder Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report Am J Cardiol 9 1962 166 181
15. A. Chaudhuri, D. Janicke, and M.F. Wilson Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction Circulation 109 2004 849 854
16. R. Diaz, E.A. Paolasso, and L.S. Piegas Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group Circulation 98 1998 2227 2234
17. J. Pache, A. Kastrati, and J. Mehilli A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy Am Heart J 148 2004 105
18. I.C. van der Horst, F. Zijlstra, and A.W. van't Hof Glucose-insulin- potassium infusion in patients treated with primary angioplasty for acute myocardial infarction: the Glucose-Insulin-Potassium Study: a randomized trial J Am Coll Cardiol 42 2003 784 791
19. T.J. Ryan, E.M. Antman, and N.H. Brooks 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) Circulation 100 1999 1016 1030
20. F. Van de Werf, D. Ardissino, and A. Betriu Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 24 2003 28 66
21. M.K. Heng, B.N. Singh, and R.M. Norris Relationship between epicardial ST-segment elevation and myocardial ischemic damage after experimental coronary artery occlusion in dogs J Clin Invest 58 1976 1317 1326
22. P. Klootwijk, A. Langer, and S. Meij Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial Eur Heart J 17 1996 689 698
23. P. Clemmensen, E.M. Ohman, and D.C. Sevilla Changes in standard electrocardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarction Am J Cardiol 66 1990 1407 1411
24. R.M. Califf, W. O'Neil, and R.S. Stack Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis Ann Intern Med 108 1988 658 662
25. G.I. Barbash, A. Roth, and H. Hod Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction Br Heart J 64 1990 241 247
26. P.R. Maroko, J.K. Kjekshus, and B.E. Sobel Factors influencing infarct size following experimental coronary artery occlusions Circulation 43 1971 67 82
27. F. Fath-Ordoubadi, and K.J. Beatt Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials Circulation 96 1997 1152 1156
28. M.K. Heng, R.M. Norris, and B.N. Singh Effects of glucose and glucose-insulin-potassium on haemodynamics and enzyme release after acute myocardial infarction Br Heart J 39 1977 748 757
29. I. Hjermann A controlled study of peroral glucose, insulin and potassium treatment in myocardial infarction Acta Med Scand 190 1971 213 218
30. Medical Research Council Working Party on the Treatment of Myocardial Infarction Potassium, glucose, and insulin treatment for acute myocardial infarction Lancet 2 1968 1355 1360
31. B. Mittra Potassium, glucose, and insulin in treatment of myocardial infarction Lancet 2 1965 607 609
32. B.L. Pentecost, N.M. Mayne, and P. Lamb Controlled trial of intravenous glucose, potassium, and insulin in acute myocardial infarction Lancet 1 1968 946 948
33. J. Pilcher, M. Etishamudin, and P. Exon Potassium, glucose and insulin in myocardial infarction Lancet 1 1967 1109
34. W.J. Rogers, A.W. Stanley Jr, and J.B. Breinig Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion Am Heart J 92 1976 441 454
35. A.W. Stanley Jr, and J.W. Prather Glucose-insulin-potassium, patient mortality and the acute myocardial infarction: results from a prospective randomised study Circulation 57 1978 61
36. L. Ceremuzynski, A. Budaj, and A. Czepiel Low-dose glucose-insulin- potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial Cardiovasc Drugs Ther 13 1999 191 200
37. L.F. Satler, C.E. Green, and K.M. Kent Metabolic support during coronary reperfusion Am Heart J 114 1987 54 58
38. G. van den Berghe, P. Wouters, and F. Weekers Intensive insulin therapy in the critically ill patients N Engl J Med 345 2001 1359 1367
39. K. Malmberg, L. Ryden, and S. Efendic Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year J Am Coll Cardiol 26 1995 57 65
40. K. Malmberg, L. Ryden, and A. Hamsten Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI study group. Diabetes Insulin-Glucose in Acute Myocardial Infarction Eur Heart J 17 1996 1337 1344
41. A.P. Furnary, G. Gao, and G.L. Grunkemeier Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting J Thorac Cardiovasc Surg 125 2003 1007 1021
42. H.L. Lazar, S.R. Chipkin, and C.A. Fitzgerald Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events Circulation 109 2004 1497 1502
43. F.R. Eberli, E.O. Weinberg, and W.N. Grice Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions Circ Res 68 1991 466 481
44. A.K. Jonassen, E. Aasum, and R.A. Riemersma Glucose-insulin-potassium reduces infarct size when administered during reperfusion Cardiovasc Drugs Ther 14 2000 615 623
45. M.G. Angelos, H.N. Murray, and R.T. Gorsline Glucose, insulin and potassium (GIK) during reperfusion mediates improved myocardial bioenergetics Resuscitation 55 2002 329 336
46. C.S. Apstein Increased glycolytic substrate protection improves ischemic cardiac dysfunction and reduces injury Am Heart J 139 2000 S107 S114
47. H.G. McDaniel, S.E. Papapietro, and W.J. Rogers Glucose-insulin-potassium induced alterations in individual plasma free fatty acids in patients with acute myocardial infarction Am Heart J 102 1981 10 15
48. C.E. Rackley, R.O. Russell Jr, and W.J. Rogers Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction Am Heart J 102 1981 1038 1049
49. C.S. Apstein, L. Deckelbaum, and M. Mueller Graded global ischemia and reperfusion. Cardiac function and lactate metabolism Circulation 55 1977 864 872
50. P.H. McNulty, S. Pfau, and L.I. Deckelbaum Effect of plasma insulin level on myocardial blood flow and its mechanism of action Am J Cardiol 85 2000 161 165
51. J. Sundell, H. Laine, and P. Nuutila The effects of insulin and short-term hyperglycaemia on myocardial blood flow in young men with uncomplicated type I diabetes Diabetologia 45 2002 775 782
52. L. Marano, A. Bestetti, and A. Lomuscio Effects of infusion of glucose-insulin-potassium on myocardial function after a recent myocardial infarction Acta Cardiol 55 2000 9 15
53. M.N. Sack, and D.M. Yellon Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: a proposed direct myocardial cell survival effect independent of metabolic modulation J Am Coll Cardiol 41 2003 1404 1407
54. M.G. McLaughlin, G.W. Stone, and E. Aymong Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial J Am Coll Cardiol 44 2004 1215 1223
55. P.K. Shah, B. Cercek, and A.S. Lew Angiographic validation of bedside markers of reperfusion J Am Coll Cardiol 21 1993 55 61
56. M.W. Krucoff, M.A. Croll, and J.E. Pope Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study. Performance of a noninvasive method for real-time detection of failed myocardial reperfusion Circulation 88 1993 437 446